Biosimilars – Where do we Stand?
Looking at the current direction of therapeutic development, it is obvious that more biologics will be introduced to manage chronic disease. Biologic agents will dominate in the realm of [...]
Looking at the current direction of therapeutic development, it is obvious that more biologics will be introduced to manage chronic disease. Biologic agents will dominate in the realm of [...]
With each passing year, technology continues to rapidly advance. The 21st century has seen the rise of mobile devices and the exponential growth of technology in all fields. Technology is [...]
Continuous glucose monitoring devices, or CGMs, are rapidly replacing fingerstick glucose meters as the standard of care for most type 1, and a number of type 2, diabetic [...]
Digital Therapeutics and the Pharmacy Benefit: Part 2 In Part 1 of this blog on Digital Therapeutics and the Pharmacy Benefit we discussed the emergence of a new class [...]
In the last several years, a new class of diagnostic and behavioral therapy options for select neuropsychiatric indications has emerged in the form of Prescription Digital Therapeutics (PDT, sometimes abbreviated [...]
We check lipids to minimize cardiovascular events. We mandate mammograms, prostate exams, colonoscopies, and bone density tests in an attempt to minimize adverse health events. And yet, healthcare still has [...]